Browsing Tag
BSX
2 posts
Boston Scientific (BSX) Q2 2026 beats estimates as MiRus TAVR investment reshapes strategy
Boston Scientific lifted FY 2026 guidance and disclosed a $1.5B MiRus TAVR bet, but BSX trades near 52-week lows as softer Q3 growth guidance stings.
July 29, 2026
Boston Scientific to take full control of Nalu Medical in $533m chronic pain tech deal
Boston Scientific is acquiring Nalu Medical for $533M to expand its pain therapy portfolio with a miniaturized, wearable neurostimulation system. Learn what this means.
October 20, 2025